$MNST

Morgan Stanley Lifts Monster Beverage Target to $110, Sees More Upside Ahead — BigGo Finance

Morgan Stanley raised its Monster Beverage (MNST) price target to $110 from $103 and reiterated an Overweight rating, implying about 9% upside versus current levels, according to the bank. FactSet shows analysts average an Overweight rating and a mean target of $100.70. Investors may look to upcoming quarterly results for volume, pricing, and margin trends.

Original reporting
Published Aug 7, 2026, 6:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 10:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$MNST
Bullish
medium confidence
Mentioned
$MNST
Relevance
7/10
alphai data visualization · based on finance.biggo.com
Decision brief

The 30-second read

$MNSTBullishMed
01

Why it matters

For MNST, the actionable element is the above-consensus target and reiterated Overweight, which can influence positioning ahead of earnings. However, without disclosed new fundamentals, the impact is likely sentiment-driven rather than thesis-breaking.

02

Market read

A single sell-side target hike above consensus can move short-term expectations, but the next earnings report is the key validation point.

03

What to watch

The article withholds the specific catalysts behind Morgan Stanley’s change, so traders may need to wait for earnings to validate the thesis (volume, pricing power, margins).

Relevance 7/10Novelty 6/10Timing: issued Friday, before the next quarterly earnings report

Background

The piece frames Morgan Stanley’s target increase versus FactSet consensus (Overweight rating, mean target $100.70) and ties it to resilience and product/international expansion themes.

Company-level read

Ticker impact

$MNSTBullishMedium confidence
Context

Morgan Stanley raised Monster Beverage’s price target to $110 from $103 and reiterated Overweight, implying a higher upside view.

Expected impact

Mild positive bias for MNST as traders react to the above-consensus target, with follow-through likely tied to upcoming earnings.

Evidence & confidence

The article provides a specific target change and rating reiteration, but it does not disclose new company fundamentals or new data beyond the analyst’s revised valuation framework.

Market effects

Reinforces positive sentiment toward the energy drink category and consumer resilience narrative, potentially supporting peer sentiment.

Limited direct regional impact; Monster’s international expansion is mentioned but no region-specific catalyst is provided.

Mostly US-focused sell-side repricing; global relevance is indirect via the international footprint theme.

Counterpoint

A higher price target may reflect valuation assumptions rather than new operational evidence, so price may fade if earnings do not confirm.

Key entities

  • Monster Beverage

    Subject of the article; Morgan Stanley raised its price target to $110 and reiterated Overweight.

  • Morgan Stanley

    Issued the revised price target and rating.

  • FactSet

    Supplied consensus rating and mean price target used for comparison.

Related articles

$MNSTMed

Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales

Monster Beverage (NASDAQ: MNST) reported Q2 CY2026 sales of $2.54 billion, up 20.2% year on year, topping Wall Street revenue expectations by 4.1%. Non-GAAP profit was $0.60 per share, about 3% above consensus. The article notes trailing 12-month revenue of $9.22 billion and a free cash flow margin averaging 24.4% over two years.

$MNSTMedAI 9/10

Monster Beverage Corp (MNST): Results of Operations and Financial Condition

Monster Beverage Corp (MNST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622396d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Relations Strategic Public Relations PondelWilkinson Inc. 2945 Townsgate Road, Suite 200 Westlake Village, CA 91361 T (310) 279 5980 W www.pondel.com CONTACTS: NEWS RELEASE Mark Astrachan SVP, Investor Relations

$MNSTMed

Morgan Stanley unveils key Monster stock price prediction

Morgan Stanley reiterated an Overweight rating and $103 price target on Monster Beverage (MNST), citing new product launches. Morgan said new items rose to nearly 15% of Monster’s US retail sales from about 3.5% end-2025 and zero in September. Monster reported Q1 2026 net sales up 26.9% to $2.35B and authorized a $500M buyback; gross margin slipped to 55% from 56.5%.

$CATMed

CAT Stock Alert: Caterpillar's AI Infrastructure Boom Is Just Getting Started

Caterpillar reported Q2 revenue up 24% to $20.54B, net income up 65% to $3.59B, and adjusted EPS up 73% to $8.17, beating Wall Street expectations, according to the company. Orders were $9.4B, backlog $72.1B. Management raised 2026 sales growth outlook to mid-to-high teens. Analysts cited data center and power demand; targets ranged from $900 (Neutral) to $1,218 (Buy).